These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12779287)

  • 21. In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit FS 30 D-coated pellets.
    Gao C; Huang J; Jiao Y; Shan L; Liu Y; Li Y; Mei X
    Int J Pharm; 2006 Sep; 322(1-2):104-12. PubMed ID: 16806752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of acrylic esters and methacyrlic esters on flotation of pellets and release rate of verapamil hydrochloride.
    Lunio R; Sawicki W
    Acta Pol Pharm; 2006; 63(1):69-74. PubMed ID: 17515332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of the ratio of two acrylic polymers on the in vitro release kinetics of ketoprofen from pellets prepared by extrusion and spheronisation technique.
    Kibria G; Ul-Jalil R
    Pak J Pharm Sci; 2008 Apr; 21(2):92-7. PubMed ID: 18390436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eudragit L/HPMCAS blend enteric-coated lansoprazole pellets: enhanced drug stability and oral bioavailability.
    Fang Y; Wang G; Zhang R; Liu Z; Liu Z; Wu X; Cao D
    AAPS PharmSciTech; 2014 Jun; 15(3):513-21. PubMed ID: 24590548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a novel osmotically driven drug delivery system for weakly basic drugs.
    Guthmann C; Lipp R; Wagner T; Kranz H
    Eur J Pharm Biopharm; 2008 Jun; 69(2):667-74. PubMed ID: 18226884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colon specific delivery of budesonide based on triple coated pellets: in vitro/in vivo evaluation.
    Varshosaz J; Emami J; Tavakoli N; Minaiyan M; Rahmani N; Dorkoosh F; Mahzouni P
    Acta Pharm; 2012 Nov; 62(3):341-56. PubMed ID: 23470347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enteric polymers as acidifiers for the pH-independent sustained delivery of a weakly basic drug salt from coated pellets.
    Körber M; Ciper M; Hoffart V; Pearnchob N; Walther M; Macrae RJ; Bodmeier R
    Eur J Pharm Biopharm; 2011 Aug; 78(3):447-54. PubMed ID: 21443950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amylopectin as a subcoating material improves the acidic resistance of enteric-coated pellets containing a freely soluble drug.
    Guo HX; Heinämäki J; Yliruusi J
    Int J Pharm; 2002 Mar; 235(1-2):79-86. PubMed ID: 11879742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Eudragit RS 30D and talc powder on verapamil hydrochloride release from beads coated with drug layered matrices.
    El-Malah Y; Nazzal S
    AAPS PharmSciTech; 2008; 9(1):75-83. PubMed ID: 18446464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the potential of a highly compressible microcrystalline cellulose as novel tabletting excipient in the compaction of extended-release coated pellets containing an extremely water-soluble model drug.
    Zeeshan F; Peh KK; Tan YT
    AAPS PharmSciTech; 2009; 10(3):850-7. PubMed ID: 19554454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
    Akhgari A; Sadeghi F; Garekani HA
    Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microencapsulated Eudragit RS30D-coated controlled-release pellets: the influence of dissolution variables and topographical evaluation.
    Govender T; Dangor CM; Chetty DJ
    J Microencapsul; 1997; 14(1):1-13. PubMed ID: 8994071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leaky enteric coating on ranitidine hydrochloride beads: dissolution and prediction of plasma data.
    Bendas ER; Ayres JW
    Eur J Pharm Biopharm; 2008 Aug; 69(3):977-85. PubMed ID: 18424095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of enteric-coated lactose on the release profile of 4-aminopyridine from HPMC matrix tablets.
    Martínez-González I; Villafuerte-Robles L
    Pharm Dev Technol; 2004; 9(2):145-53. PubMed ID: 15202573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development.
    Gupta VK; Beckert TE; Price JC
    Int J Pharm; 2001 Feb; 213(1-2):83-91. PubMed ID: 11165096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
    Liu Y; Sun Y; Sun J; Zhao N; Sun M; He Z
    Int J Pharm; 2012 Apr; 426(1-2):21-28. PubMed ID: 22266529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pectin/chitosan/Eudragit RS mixed-film coating for bimodal drug delivery from theophylline pellets: preparation and evaluation.
    Ghaffari A; Oskoui M; Helali K; Bayati K; Rafiee-Tehrani M
    Acta Pharm; 2006 Sep; 56(3):299-310. PubMed ID: 19831279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and in vitro-in vivo evaluation of none gastric resident dipyridamole (DIP) sustained-release pellets with enhanced bioavailability.
    Xu L; Luo Y; Feng J; Xu M; Tao X; He H; Tang X
    Int J Pharm; 2012 Jan; 422(1-2):9-16. PubMed ID: 22001837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.